Congress nearly passed legislation to restrict pharmacy benefit manager business practices at the end of 2024.
Investors in CVS Health Corp. (NYSE: CVS) will be looking for signs of improvement when the company's fourth-quarter and full-year earnings are released Wednesday morning ahead of the opening bell.
The biggest pharmacy benefit managers have made efforts to improve relationships with pharmacies, health insurers, employers ...
The new agreement with Express Scripts could be a big boost for Kroger’s pharmacy business, which the company said took a hit ...
The FTC called out the nation’s leading pharmacy benefit managers for inflating pharmacy costs, affecting both employers and ...
The two have mended fences after a nasty contract dispute in 2022 caused Kroger pharmacies to go out of network with Express ...
FOX 9 Minneapolis-St. Paul on MSN3d
Generic prescription drug prices marked up as high as 5,000%, investigation findsA new FTC report found that pharmacy benefit managers have inflated the price of life-saving generic prescription drugs, finding the companies sometimes increased prices of these drugs by 1,000 ...
New York would become the first state to force pharmacy benefit managers to publicly reveal how much they profit from rebates issued by drug ...
The parents of Cole Schmidtknecht are suing Walgreens and OptumRx, a subsidiary of UnitedHealth Group, over the 22-year-old ...
The main focus in Teva’s innovative portfolio continues to be neuroscience and immunology, with clinical trials for three key assets underway: olanzapine for treatment of schizophrenia, ...
In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus. Lantus cost $292 for a 30-day supply. Drugmaker Viatris launched two versions ...
The Odessa American is the leading source of local news, information, entertainment and sports for the Permian Basin.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback